139524-57-5 Usage
Description
1,4-DIOXA-7-AZA-SPIRO[4.4]NONANE-7-CARBOXYLIC ACID BENZYL ESTER is a complex chemical compound characterized by its unique molecular structure, featuring a carboxylic acid benzyl ester, a spiro ring, and a dioxane ring. 1,4-DIOXA-7-AZA-SPIRO[4.4]NONANE-7-CARBOXYLIC ACID BENZYL ESTER holds potential for various industrial and pharmaceutical applications due to its distinctive properties, although further investigation is required to fully understand its uses and potential hazards.
Uses
Used in Pharmaceutical Industry:
1,4-DIOXA-7-AZA-SPIRO[4.4]NONANE-7-CARBOXYLIC ACID BENZYL ESTER is used as a pharmaceutical intermediate for the synthesis of various drugs and active pharmaceutical ingredients. Its unique structure and properties may contribute to the development of novel therapeutic agents with specific pharmacological actions.
Used in Chemical Synthesis:
In the chemical industry, 1,4-DIOXA-7-AZA-SPIRO[4.4]NONANE-7-CARBOXYLIC ACID BENZYL ESTER serves as a key intermediate in the synthesis of complex organic compounds and specialty chemicals. Its unique structure allows for the creation of new molecules with potential applications in various fields.
Used in Research and Development:
1,4-DIOXA-7-AZA-SPIRO[4.4]NONANE-7-CARBOXYLIC ACID BENZYL ESTER is utilized in research and development settings to explore its chemical properties, reactivity, and potential applications in various fields. Its unique structure provides a basis for studying new reactions and mechanisms, contributing to the advancement of chemical science.
Check Digit Verification of cas no
The CAS Registry Mumber 139524-57-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,9,5,2 and 4 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 139524-57:
(8*1)+(7*3)+(6*9)+(5*5)+(4*2)+(3*4)+(2*5)+(1*7)=145
145 % 10 = 5
So 139524-57-5 is a valid CAS Registry Number.
139524-57-5Relevant articles and documents
HETEROCYCLIC COMPOUND
-
Page/Page column 62, (2013/02/28)
Provided is a compound useful for the prophylaxis or treatment of cancer. The present invention relates to a compound represented by formula (I): wherein each symbol in the formula is as defined in the specification, or a salt thereof or a prodrug thereof, which is useful for the prophylaxis or treatment of cancer.
HIV Integrase Inhibitors
-
Page/Page column 34, (2010/11/29)
The invention encompasses series bicyclic pyrimidinone compounds of Formula I which inhibit HIV integrase and prevent viral integration into human DNA. This action makes the compounds useful for treating HIV infection and AIDS. The invention also encompasses pharmaceutical compositions and methods for treating those infected with HIV.
Preparation and in Vitro and in Vivo Evaluation of Quinolones with Selective Activity against Gram-Positive Organisms
Cooper, Curt S.,Klock, Pamela L.,Chu, Daniel T. W.,Hardy, Dwight J.,Swanson, Robert N.,Plattner, Jacob J.
, p. 1393 - 1398 (2007/10/02)
A series of quinolones were prepared which contained oximes or substituted oximes as replacements for the amine substituents normally found on the pyrrolidine or piperidine fragments of quinolone antibacterial agents.These substituents led to compounds that had selective activity against Gram-positive organisms.These compounds showed in vivo activity Staphylococcus aureus.Only compound 29 had in vivo activity against Streptococcus pneumoniae.
